Health Cor Management, L.P. Horizon Therapeutics Public LTD CO Transaction History

Health Cor Management, L.P.

$106 Million
Q4 2022

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $39.7 Million - $57.1 Million	-674,320 Reduced 74.61%	229,530 $14.2 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $15.4 Million - $22.5 Million	193,740 Added 27.28%	903,850 $72.1 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $10.6 Million - $13.4 Million	-122,160 Reduced 14.68%	710,110 $74.7 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $44 Million - $53.5 Million	-445,958 Reduced 34.89%	832,270 $89.7 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $3.97 Million - $4.77 Million	43,180 Added 3.5%	1,278,228 $140 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $42.3 Million - $47.1 Million	-490,602 Reduced 28.43%	1,235,048 $116 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $28.2 Million - $37.5 Million	-392,440 Reduced 18.53%	1,725,650 $159 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $22 Million - $27.7 Million	327,780 Added 18.31%	2,118,090 $155 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $76.7 Million - $111 Million	1,389,270 Added 346.42%	1,790,310 $139 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $11.9 Million - $22.4 Million	-393,440 Reduced 49.52%	401,040 $22.3 Million
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $19.8 Million - $30.6 Million	794,480 New	794,480 $23.5 Million
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $66.9 Million - $96.4 Million	-2,628,840 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $3.79 Million - $4.61 Million	-164,830 Reduced 5.9%	2,628,840 $71.6 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $63.7 Million - $79.6 Million	2,793,670 New	2,793,670 $67.2 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.

Account